Latest Blogs

Feb 14, 2018
Patient advocate Ms. Carole Seigel discusses ASCO's new clinical practice guideline on managing immune-related adverse events for patients treated with checkpoint inhibitors.  
Feb 13, 2018
A recent event brought home the significance of how devastating news is received and how we react to a potentially life-changing message.
Feb 05, 2018
Almost every day a patient (and often many more than one) asks Dr. Evan Hall, “How will my cancer diagnosis affect my life?” This is a difficult question to answer. 
Feb 01, 2018
"Can we increase the chances to make early diagnoses in patients with cancer? Yes, we can, I can, but how?" asks Dr. Jose Angel Sanchez.
Subscribe to this column

Clifford A. Hudis, MD, FACP, FASCO

Clifford A. Hudis, MD, FACP, FASCO, is the CEO of ASCO. Prior to this role, he served as Chief of the Breast Medicine Service and an attending physician at Memorial Sloan Kettering Cancer Center and as a professor in the Department of Medicine at Weill Cornell Medical College. He is a Past President of ASCO. His research interests include all areas of care related to breast cancer, with a focus on the development of novel systemic therapies and prevention interventions related to the obesity and inflammation. Follow Dr. Hudis on Twitter @CliffordHudis.

Feb 01, 2018
The daily challenges of science and clinical care require the collective “we” to make the big, bold, creative advances that ultimately transform cancers as a whole, but individual lives around the world are changed one at the time, by the “I.” 
Dec 06, 2017
For your consideration (and response), here is an update from the most recent Board meeting that took place on November 16-18, 2017, including the establishment of Core Values and a 5-year strategic plan.
Jan 25, 2017
As ASCO and the oncology community prepare for World Cancer Day on February 4, 2017, I've been reflecting on the day's theme of "We can. I can," which recognizes the individual responsibilities and opportunities that are built on the advances we make collectively.
Aug 29, 2016
ASCO CEO Dr. Clifford Hudis describes the Society's Global Oncology programs and the initiatives of the Global Oncology Leadership Task Force. Dr. Hudis asks challenging questions about providing optimal cancer care in low-income countries. 
Jul 29, 2014
I am writing because I really want everyone’s input—comments, email, phone calls, written notes—on an issue that has been a slowly growing concern for all of us at ASCO: Our election and specifically our members’ participation in it. While we may pat ourselves on our collective backs for selecting...
Jul 10, 2014
One of the joys of aging—and there actually are a few—is the opportunity to use decades of experience to begin to see and understand what really matters over the long term. What kind of work, what clinical focus, what research paths turn out to be truly transformative and illuminating for our field...

Pages